Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke

Summary

Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke is a clinical trial^[1].

Key Facts

• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke is in the country of Taiwan^[2].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's instance of is recorded as clinical trial^[3].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's start time is recorded as +2019-10-01T00:00:00Z^[4].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's end time is recorded as +2022-07-31T00:00:00Z^[5].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's contributor to the creative work or subject is recorded as National Taiwan University Hospital^[6].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's main subject is recorded as diabetes^[7].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's main subject is recorded as stroke^[8].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's number of participants is recorded as {'unit': '1', 'amount': '+200'}^[9].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's title is recorded as Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke: A Randomized Controlled Trial^[10].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's short name is recorded as ATTESTS^[11].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}^[12].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's ClinicalTrials.gov ID is recorded as NCT04419337^[13].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+99'}^[14].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's research intervention is recorded as metformin^[15].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's research intervention is recorded as (RS)-pioglitazone^[16].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's research intervention is recorded as gliflozins^[17].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's clinical trial phase is recorded as phase II clinical trial^[18].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's research subject recruitment status is recorded as recruiting^[19].
• Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke's study type is recorded as interventional study^[20].